Home
Scholarly Works
Phase I/II study of GTI-2040 plus docetaxel as...
Conference

Phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer (NSCLC)

Authors

Leighl N; Laurie S; Knox J; Ellis P; Shepherd F; Burkes R; Pond G; Zwiebel J; Moore M

Volume

49

Pagination

pp. S256-S256

Publisher

ELSEVIER IRELAND LTD

Publication Date

July 1, 2005

Name of conference

11th World Conference on Lung Cancer

Conference place

Barcelona, SPAIN

Conference start date

July 3, 2005

Conference end date

July 6, 2005

Conference proceedings

LUNG CANCER

ISSN

0169-5002

Contact the Experts team